Drug Trial Radar · NCT03748641
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
765
Actual
Start
Jan 25, 2019
Primary completion
Oct 8, 2021
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Nov 21, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness of niraparib in combination with abiraterone acetate plus prednisone (AAP) compared to AAP and placebo.
Conditions
- Castration-Resistant Prostatic Cancer
Interventions
NiraparibDrug
Participants will receive niraparib 200 mg capsules or tablets once daily.
Abiraterone AcetateDrug
Participants will receive AA 1000 mg tablets once daily.
PrednisoneDrug
Participants will receive prednisone 10 mg tablets daily.
PlaceboDrug
Participants will receive matching placebo once daily.
New Formulation of Niraparib and Abiraterone Acetate (AA)Drug
Participants will receive a new formulation of niraparib 200 mg and AA 1000 mg tablets once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR)Time frame: Up to 32 months
- Cohort 1 Breast Cancer Gene (BRCA) Subgroup: Radiographic Progression-Free Survival (rPFS) as Assessed by Blinded Independent Central Review (BICR)Time frame: Up to 32 months
Locations
318 sites in 29 countries. Site status is shown where the registry gives one.
Urology Centers Of Alabama
Homewood, Alabama
Mayo Clinic Arizona
Phoenix, Arizona
Urological Associates of Southern Arizona, P.C.
Tucson, Arizona
Arkansas Urology
Little Rock, Arkansas
Kaiser Permanente
Riverside, California
San Bernardino Urological Associates
San Bernardino, California
University of California San Francisco
San Francisco, California
Sansum Clinic Pharm
Santa Barbara, California
The Urology Center of Colorado
Denver, Colorado
Colorado Clinical Research
Lakewood, Colorado
VA Connecticut Healthcare
West Haven, Connecticut
Bay Pines VA Healthcare System
Bay Pines, Florida
Advanced Urology Institute
Daytona Beach, Florida
University of Florida Health Jacksonville
Jacksonville, Florida
Mayo Clinic - Division Of Hematology/oncology
Jacksonville, Florida
Veterans Affairs Medical Ctr
Hines, Illinois
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana
First Urology
Jeffersonville, Indiana
University of Kansas Medical Center
Kansas City, Kansas
Norton Healthcare
Louisville, Kentucky
Ochsner Clinic Foundation
New Orleans, Louisiana
Rcca Md, Llc
Bethesda, Maryland
Chesapeake Urology Research Associates
Towson, Maryland
Massachusetts General
Boston, Massachusetts
Michigan Institute of Urology
Troy, Michigan
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri
Adult Pediatric Urology & Urogynecology, P.C
Omaha, Nebraska
Nebraska Cancer Specialists
Omaha, Nebraska
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada
Delaware Valley Urology, LLC
Mount Laurel, New Jersey
New York Oncology Hematology
Albany, New York
Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Upstate Cancer Center
Syracuse, New York
Helios Clinical Research, LLC
Middleburg Heights, Ohio
Oregon Urology Institute
Springfield, Oregon
MidLantic Urology
Bala-Cynwyd, Pennsylvania
Lancaster Urology
Lancaster, Pennsylvania
VA Pittsburgh
Pittsburgh, Pennsylvania
Carolina Urologic Research Center
Myrtle Beach, South Carolina
Showing 40 of 318 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.